Aptevo
$0.75879876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.7587
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.0275 (-3.57%) Today
+$0.0162 (2.18%) As of 4:03 PM EDT after-hours
Why Robinhood?
You can buy or sell Aptevo and other stocks, options, ETFs, and crypto commission-free!
About APVO
Aptevo Therapeutics Inc. Common Stock, also called Aptevo, is a biotechnology company, which engages in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics to improve patients lives. Read More Its pipeline includes APVO210, APVO436, ROR1 Candidate, and ALG.APV-527. The company was founded on February 22, 2016 and is headquartered in Seattle, WA.
Employees
118
Headquarters
Seattle, Washington
Founded
2016
Market Cap
34.73M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
754.65K
High Today
$0.7829
Low Today
$0.7402
Open Price
$0.7771
Volume
442.91K
52 Week High
$5.73
52 Week Low
$0.49
Collections
Price Paid on Robinhood
36% Lower
Right Now
52 Week Low
$0.731
Average Price Paid
$1.18
52 Week High
$6.35
APVO Earnings
-$0.63
-$0.52
-$0.41
-$0.30
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
-$0.30 per share